Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00897637 · ClinicalTrials.gov registry record
Gene Expression Profiles to Categorize Wilms Tumors
A clinical trial of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 600
- Enrollment target
- 2
- Study locations
NCT00897637: Completed study of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor, sponsored by Children's Oncology Group.
NCT00897637 is a study of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor that has completed, run by Children's Oncology Group. The registered enrollment target is 600 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00897637, a study of Recurrent Wilms Tumor and Other Childhood Kidney Tumors and Stage IV Wilms Tumor, has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 2
- Study locations
Study Summary
This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (2)
California
- Children's Oncology Group - Arcadia
Florida
- Saint Mary's Hospital - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2004-02 |
What the finished NCT00897637 record still lists
NCT00897637 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 6 conditions, with Recurrent Wilms Tumor and Other Childhood Kidney Tumors appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00897637 reports a single indexed study location in California, Florida.
Frequently Asked Questions
What is clinical trial NCT00897637 about?
NCT00897637 is a clinical study titled "Gene Expression Profiles to Categorize Wilms Tumors". This laboratory study is using gene expression profiling to identify different categories of Wilms tumors. Studying the genes expressed in samples of tumor tissue from patients with cancer may help doctors identify biomarkers related to cancer.
What is the current status of trial NCT00897637?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2004-02.
What conditions does trial NCT00897637 study?
This clinical trial studies the following conditions: Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Stage IV Wilms Tumor, Stage V Wilms Tumor, Stage I Wilms Tumor, Stage II Wilms Tumor.
What interventions are being tested in trial NCT00897637?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00897637?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00897637 being conducted?
This trial has 2 study locations across California, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia